Tuesday, 7 August 2012

Novel Target for ALS Treatment Identified

An inflammatory monocyte population serves as a potential therapeutic target for amyotrophic lateral sclerosis (ALS). Although the mechanism of ALS is not completely understood, inflammation is believed to play a role in the disease process. A recent study by Howard Weiner and colleagues at Harvard Medical School and Tufts School of Medicine investigated the role of inflammation in a mouse model of ALS. Weiner and colleagues found that the recruitment of activated ...

via Medindia Health News More READ

No comments:

Post a Comment